Dashboard
Manage Tickers

PGEN


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

assessing-precigen-insights-from-5-financial-analysts
Assessing Precigen: Insights From 5 Financ...
08/15/2024 19:01:48

jmp-securities-maintains-market-outperform-on-precigen-lowers-price-target-to-7
JMP Securities Maintains Market Outperform...
08/15/2024 15:37:02

JMP Securities analyst Jason Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and lowers the price target fr...

titan-machinery-reports-weak-preliminary-results-joins-precigen-gogoro-and-other-big-stocks-moving-lower-in-thursday-pre-market-session
Titan Machinery Reports Weak Preliminary R...
08/15/2024 12:11:53

hc-wainwright--co-maintains-buy-on-precigen-lowers-price-target-to-4
HC Wainwright & Co. Maintains Buy on Preci...
08/15/2024 12:00:09

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and lowers the price targ...

why-lumentum-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarket
Why Lumentum Shares Are Trading Higher By ...
08/15/2024 10:32:30

precigen-q2-2024-gaap-eps-023-misses-010-estimate-sales-71700k-miss-128m-estimate
Precigen Q2 2024 GAAP EPS $(0.23) Misses $...
08/14/2024 20:10:42

Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.10) by...

more-than-20m-bet-on-precigen-check-out-these-3-stocks-under-5-insiders-are-aggressively-buying
More Than $20M Bet On Precigen? Check Out ...
08/14/2024 12:57:03

precigen-shares-are-trading-lower-after-the-company-announced-the-pricing-of-a-30-million-public-offering-of-35294118-shares-at-085share
Precigen shares are trading lower after th...
08/08/2024 11:48:21

why-digital-turbine-shares-are-trading-higher-by-over-20-here-are-20-stocks-moving-premarket
Why Digital Turbine Shares Are Trading Hig...
08/08/2024 10:02:17

reported-earlier-precigen-prices-30m-public-offering-of-35294118-common-stock-at-085share
Reported Earlier, Precigen Prices $30M Pub...
08/08/2024 05:43:18

Precigen intends to use the net proceeds from the offering for advancing PRGN-2012 to regulatory approval and commercial readin...

precigen-strategically-prioritizes-portfolio-to-focus-on-first-potential-gene-therapy-launch-including-a-reduction-of-over-20-of-its-workforce
Precigen Strategically Prioritizes Portfol...
08/06/2024 20:27:23

– PRGN-2012 is on track for a rolling BLA submission under an accelerated approval pathway; patient enrollment initiated in the...

precigen-proposes-30m-public-offering-of-common-stock
Precigen Proposes $30M Public Offering Of ...
08/06/2024 20:26:33

Precigen, Inc. (NASDAQ:PGEN) today announced it has commenced a $30.0 million underwritten public offering of its common stock....

precigen-to-spearhead-first-potential-gene-therapy-launch
Precigen To Spearhead First Potential Gene...
07/23/2024 12:18:14

–  Company strengthens focus on building and optimizing commercial readiness and pre-launchactivities for PRGN-2012 in recurren...

jmp-securities-reiterates-market-outperform-on-precigen-maintains-14-price-target
JMP Securities Reiterates Market Outperfor...
06/04/2024 12:32:39

JMP Securities analyst Jason Butler reiterates Precigen (NASDAQ:PGEN) with a Market Outperform and maintains $14 price target.

why-science-applications-international-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Science Applications International Sha...
06/03/2024 17:56:53

6-analysts-assess-precigen-what-you-need-to-know
6 Analysts Assess Precigen: What You Need ...
06/03/2024 17:00:15

hc-wainwright--co-reiterates-buy-on-precigen-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Prec...
06/03/2024 16:21:09

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Precigen (NASDAQ:PGEN) with a Buy and maintains $6 price t...

stifel-maintains-buy-on-precigen-raises-price-target-to-10
Stifel Maintains Buy on Precigen, Raises P...
06/03/2024 16:20:22

Stifel analyst Benjamin Burnett maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $7 to $10.

watching-precigen-shares-spiking-higher-as-traders-circulate-analyst-comments-suggesting-rrp-data-looks-great-52-cr-and-differentiated-from-ino-3107-we-think-prgn-2012-looks-approvable
Watching Precigen; Shares Spiking Higher A...
06/03/2024 14:27:20

precigen-announces-study-data-for-prgn-2012-for-recurrent-respiratory-papillomatosis-patients-phase-12-pivotal-study-met-primary-and-efficacy-endpoints
Precigen Announces Study Data For PRGN-201...
06/03/2024 13:31:38

–   Phase 1/2 pivotal study met the primary safety and efficacy endpoints ––   51% (18 out of 35) of patients achieved Complete...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION